Considering That the coronavirus pandemic began, researchers have been tasked with responding to an essential concern: For those who have recovered from a coronavirus infection, do COVID-19 antibodies offer defense from future infections, and for the length of time?
A study published Wednesday in the journal JAMA Internal Medicine suggests that those who have COVID-19 antibodies have a considerably lower threat of reinfection compared to those who do not have them.
Simply under 12%of those checked were discovered to be favorable for coronavirus antibodies, while some 88%were unfavorable for them. The scientists, utilizing follow-up information, discovered that less than 1%– 0.3%to be exact– of those who had coronavirus antibodies tested positive for a COVID-19 infection at the 90- day mark. (iStock).
PFIZER COVID-19 VACCINE 94?FECTIVE IN REAL-WORD CONDITIONS: STUDY
Simply under 12%of those tested were found to be positive for coronavirus antibodies, while some 88%were negative for them.
CLICK HERE FOR FULL CORONAVIRUS COVERAGE
” In this mate research study, deidentified information from commercial labs suggest that the presence of antibodies to SARS-CoV-2 is associated with a reduced threat of having a subsequent favorable NAAT outcomes, which might be a proxy representing a new infection or might represent continued viral shedding depending on the context and timing.
Leave a Reply